Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer
The Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most aggressive and dangerous cancerous diseases, leading to a high rate of mortality. Therefore, the development of new, more efficient treatment approaches is necessary to cure this illness. Peptide-based drug targeting provides a new tool...
Saved in:
Main Authors: | Levente E. Dókus (Author), Eszter Lajkó (Author), Ivan Ranđelović (Author), Diána Mező (Author), Gitta Schlosser (Author), László Kőhidai (Author), József Tóvári (Author), Gábor Mező (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SREKA-targeted liposomes for highly metastatic breast cancer therapy
by: Balázs Vári, et al.
Published: (2023) -
Topoisomerases inhibition and DNA binding mode of daunomycin-oligoarginine conjugate
by: Valeria Visone, et al.
Published: (2020) -
Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker
by: Marco Zambra, et al.
Published: (2023) -
Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines
by: Márton Kalabay, et al.
Published: (2022) -
Evolution of phage display libraries for therapeutic antibody discovery
by: Yang Zhang
Published: (2023)